These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34721444)

  • 1. Editorial: Sensitization and Desensitization in Organ Transplantation.
    Anwar IJ; Jackson AM; Locke JE; Kwun J
    Front Immunol; 2021; 12():784472. PubMed ID: 34721444
    [No Abstract]   [Full Text] [Related]  

  • 2. Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies.
    Bućin D; Gustafsson R; Ekmehag B; Kornhall B; Algotsson L; Lund U; Otto G; Koul B
    Transplantation; 2010 Dec; 90(11):1220-5. PubMed ID: 20885338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization for solid organ and hematopoietic stem cell transplantation.
    Zachary AA; Leffell MS
    Immunol Rev; 2014 Mar; 258(1):183-207. PubMed ID: 24517434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies.
    Kardol-Hoefnagel T; Otten HG
    Transplantation; 2021 Jul; 105(7):1459-1470. PubMed ID: 33208690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers.
    Joher N; Matignon M; Grimbert P
    Front Immunol; 2021; 12():688301. PubMed ID: 34093594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation: Donor-specific HLA antibodies and renal allograft failure.
    Loupy A; Jordan SC
    Nat Rev Nephrol; 2013 Mar; 9(3):130-1. PubMed ID: 23399581
    [No Abstract]   [Full Text] [Related]  

  • 7. Desensitization in heart transplant recipients: Who, when, and how.
    Shah KS; Patel J
    Clin Transplant; 2019 Aug; 33(8):e13639. PubMed ID: 31206862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying HLA-specific antibodies in patients undergoing desensitization.
    Zachary A; Reinsmoen NL
    Curr Opin Organ Transplant; 2011 Aug; 16(4):410-5. PubMed ID: 21666475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the histocompatibility laboratory in desensitization for transplantation.
    Leffell MS; Zachary AA
    Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Heart Transplantation After Desensitization in a Patient With Extremely High Panel-Reactive Antibody Levels and Pretransplant Donor-Specific Antibody: A Case Report.
    Nakamura Y; Yoshioka D; Miyagawa S; Yoshikawa Y; Hata H; Matsuura R; Toda K; Sawa Y
    Transplant Proc; 2018 Dec; 50(10):4067-4070. PubMed ID: 30577317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization in kidney transplantation: review and future perspectives.
    Abu Jawdeh BG; Cuffy MC; Alloway RR; Shields AR; Woodle ES
    Clin Transplant; 2014 Apr; 28(4):494-507. PubMed ID: 24621089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
    Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation.
    In JW; Nam M; Rho EY; Shin S; Hong YJ; Park KU; Song EY
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients.
    Khan MT; Hamid RB; Sarfaraz S; Lal N; Ahmed J; Luxmi S
    Saudi J Kidney Dis Transpl; 2020; 31(6):1432-1438. PubMed ID: 33565460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimising the clinical impact of the alloimmune response through effective histocompatibility testing for organ transplantation.
    Dyer PA; Claas FH; Doxiadis II; Glotz D; Taylor CJ
    Transpl Immunol; 2012 Oct; 27(2-3):83-8. PubMed ID: 22732444
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
    Moris D; Cendales LC
    Front Immunol; 2021; 12():682180. PubMed ID: 34456906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside.
    Focosi D
    Int Rev Immunol; 2016 Jul; 35(4):351-368. PubMed ID: 27120091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.